Media contributions
1Media contributions
Title Wegovy approved to treat severe fatty liver disease Degree of recognition National Media name/outlet NewsGP Media type Web Country/Territory Australia Date 1/04/26 Description Experts say the TGA’s provisional approval of the new indication could help slow disease progression, alongside other early intervention strategies....
Chair of RACGP Expert Committee – Quality Care, Professor Mark Morgan, stressed that GPs should be mindful of the cost barriers that come with Wegovy’s new indication.
‘Before rushing to prescribe these medicines to people with MASH there is a need to consider affordability until the PBS catches up to fund use of these medicines in line with TGA-approved indications,’ he said.
There are also side effects to consider, such as nausea, diarrhoea, mental health deterioration, as well as the challenge of rebound weight gain.Producer/Author Karen Burge URL https://www1.racgp.org.au/newsgp/clinical/wegovy-approved-to-treat-severe-fatty-liver-diseas?utm_source=racgpnewsgpnewsletter&utm_campaign=newsgpedm&utm_medium=email Persons Mark Morgan